Clinical Trials Directory

Trials / Sponsors / Spinogenix

Spinogenix

Industry · 9 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingEfficacy and Safety of Tazbentetol in ALS Participants
Amyotrophic Lateral Sclerosis
Phase 2 / Phase 32026-03-01
Not Yet RecruitingA Study to Investigate the Effects and Safety of SPG601 for the Treatment of Fragile X Syndrome in Male Partic
Fragile X Syndrome (FXS)
Phase 2 / Phase 32026-03-01
TerminatedExtension Study of Participants From SPG302-ALS-001
Amyotrophic Lateral Sclerosis (ALS)
Phase 22025-05-29
TerminatedExtension Study of Participants From SPG302-ALZ-101
Alzheimer's Disease
Phase 22025-03-25
Active Not RecruitingStudy of SPG302 in Adults With Schizophrenia
Schizophrenia
Phase 22024-08-01
Active Not RecruitingStudy of SPG302 in Adult Participants With Mild-to-Moderate Alzheimer's Disease (AD)
Alzheimer Disease
Phase 22024-07-29
CompletedStudy of SPG601 in Adult Men With Fragile X Syndrome
Fragile X Syndrome
Phase 22024-07-05
CompletedStudy of SPG302 in Healthy Volunteers and ALS Participants
Amyotrophic Lateral Sclerosis
Phase 12023-07-03
AvailableIntermediate-size Patient Population Expanded Access Protocol
ALS (Amyotrophic Lateral Sclerosis)
——